Julien Peron, Valerie Boige, Pascale Mariani, Clarisse Eveno, Denis Michel Smith, Laurence Gladieff, Judith Raimbourg, Nicolas Pirro, Julien Edeline, Marie Viala, Cecile Brigand, Cécile Vicier, Pascale Tomasini, Diego Tosi, Sara Calattini, Sylvie Bin, Fabien Subtil, Benoît You, Vahan Kepenekian. "IMMUNORARE 5 : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Peritoneal Mesotheliomas Cohort.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps4236